Kapil Bahl

1PUBLICATIONS
10CO-AUTHORS
Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Sep 22, 2023
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection.

Gabriela Baldeon Vaca, Michelle Meyer, Ana Cadete

Pageof 1

Frequent Collaborators

1 joint publications

Gabriela Baldeon Vaca

1 joint publications

Michelle Meyer

1 joint publications

Ana Cadete

1 joint publications

Chiaowen Joyce Hsiao

1 joint publications

Emily Azcue

1 joint publications

Colette A Pietzsch

1 joint publications

Chad E Mire

1 joint publications

Matthew A Hyde

1 joint publications

Margaret E Comeaux

1 joint publications

Alexander Bukreyev

Frequent Collaborators

1 joint publications

Gabriela Baldeon Vaca

1 joint publications

Michelle Meyer

1 joint publications

Ana Cadete

1 joint publications

Chiaowen Joyce Hsiao

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.1K
See more related videos

Top Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.1K
See more related videos